Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Forecasted Market Size Estimates For The Induced Pluripotent Stem Cell (iPSC) Market Between 2025 And 2029?
The induced pluripotent stem cell (ipsc) market has experienced swift expansion in recent years. Projections indicate its value will increase from $3.3 billion in 2024 to $3.67 billion in 2025, at a compound annual growth rate (CAGR) of 11.3%. This historical growth can be attributed to factors such as increasing healthcare expenditure, a rise in funding, a heightened awareness of the medicinal potential of stem cell products, the use of induced pluripotent stem cell (IPSC) in drug discovery, a growing demand for personalized medicine, and the cost-effective advantages of IPSC for drug discovery.
The induced pluripotent stem cell (ipsc) market is projected for substantial expansion in the coming years. Its size is expected to reach $5.29 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.6%. Factors driving this growth during the forecast period include the rising incidence of chronic and genetic diseases, expanding genomic projects, the creation of IPSC-derived disease models, governmental support, and swift technological advancements. Key trends expected over this period encompass the development of pluripotent stem cells for Parkinson’s disease (PD) and Type I diabetes, various strategic collaborations and partnerships, the advancement of induced pluripotent stem cell IPSC-derived NK cells, the application of induced pluripotent stem cell (IPSC) in cell therapy, increased investment in regenerative medicine research and development, and the creation of IPSC expansion media and personalized IPSCs.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp
Which Factors And Drivers Are Influencing The Induced Pluripotent Stem Cell (iPSC) Market In 2025?
The induced pluripotent stem cell market’s expansion is significantly propelled by the rising occurrence of chronic conditions. Induced pluripotent stem cells offer a treatment option for chronic ailments like heart disease, cancer, stroke, and diabetes. These stem cells are derived from various tissues of a child or an adult and are genetically altered to mimic the behavior of embryonic stem cells. A report from the Partnership to Fight Chronic Disorder (PFCD) revealed that 45% of 133 million Americans were affected by at least one chronic disorder. Furthermore, an estimated 7 out of 10 deaths in the USA, totaling around 1.7 million, are attributed to chronic disorders, with induced pluripotent stem cell treatment potentially offering control over these fatalities. Consequently, the escalating rates of chronic diseases are fueling the demand within the induced pluripotent stem cell treatment market.
What Are The Different Segment Classifications Within The Induced Pluripotent Stem Cell (iPSC) Market?
The induced pluripotent stem cell (ipsc)market covered in this report is segmented –
1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types
2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy
3) By End-User: Hospitals, Research Laboratories
Subsegments:
1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing; Disease Modeling And Regenerative Therapies
2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair; Fibroblast-Based Disease Research
3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research; Skin Regeneration Therapies
4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research; Amniotic Fluid-Based Regenerative Applications
5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling; Cardiomyocytes For Heart Disease Studies; Endothelial Cells For Vascular Research
What Trends Are Expected To Drive The Induced Pluripotent Stem Cell (iPSC) Market?
Businesses operating in the Induced Pluripotent stem cell market are actively seeking strategic partnerships and collaborations to enable their entry into new geographical areas and to expand their product portfolios. For instance, in January 2022, Bristol Myers Squibb and Century Therapeutics formed a strategic collaboration dedicated to developing IPSC-derived allogenic cell therapies for addressing acute myeloid leukemia and multiple myeloma. Moreover, in May 2022, Evotec and Sernova announced a strategic partnership aimed at advancing IPSC-based beta cell replacement therapy for the management of type 1 and type 2 diabetes.
Which Key Market Players Are Investing In Expansion And Innovation Of Induced Pluripotent Stem Cell (iPSC) Market?
Major companies operating in the induced pluripotent stem cell (iPSC) market include FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio, Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, Takaria Bio, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, MSD, Pfizer, Roche, Pharmasyntez, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, GlaxoSmithKline, Parexel, Bayer, Fate Therapeutics, Athersys, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, VistaGen Therapeutics, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report
Which Global Regions Are Influencing The Competitive Landscape Of The Induced Pluripotent Stem Cell (iPSC) Market?
North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2024. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (IPSC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Induced Pluripotent Stem Cell (iPSC) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp
Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2025, By The Business Research Company
Stem Cell Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report
Stem Cell Cord Blood Banking Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report
Stem Cells Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model